Icd Case No. 2
Icd Case No. 2
Icd Case No. 2
2
OUTLINE
• History & PE
• Radiographic image
• Differential diagnosis
• Diagnosis
• Achalasia Discussion
• Prognosis
• Treatment
• Ethical Issues
CC: progressive dysphagia
(solid)
HISTORY
• Ankylosing Spondylitis
1999
STRICTURES DES
ACHALASIA
FINAL DIAGNOSIS
ACHALASIA
DIAGNOSIS
• Barium study
• Esophageal manometry
• Endoscopy with biopsy
• Chest radiograph
• CT scan
• Trans-abdominal ultrasound
DIAGNOSIS
Barium study
DIAGNOSIS
• Esophageal manometry
– Usually required for confirmation of diagnosis
• Elevated resting LES pressure
• Incomplete LES relaxation
– Absence of peristalsis
DIAGNOSIS
• Endoscopy
– Must rule out malignancy
– Reveals dilated esophagus with normal mucosa
– Retained fluid/food
DIAGNOSIS
• Chest radiograph
– With severe disease, may readily see the large,
dilated esophagus with air fluid level at the
aortic arch or above
– Stomach bubble frequently absent
DIAGNOSIS
• CT Scan
– Not typically used for diagnosis
– nonspecific and insensitive in the early stages of
achalasia
– Seen as dilated luminal structure with retained
debris and narrowing at level where it enters the
stomach
DIAGNOSIS
• Trans-abdominal Ultrasonography
– homogenous esophageal wall thickening and dilat
ation of the esophagus)
– technique is not yet prevalent in clinical practice.
DISCUSSION
• A rare disease
• loss of ganglion cells w/in myenteric plexus
(1:100,000)
• Idiopathic origin (autoimmune, inflammatory
or hereditary)
• 25-60 y/o
• M=F
DISCUSSION
• Progressive dilatation and sigmoid deformity
of the esophagus w/ hypertrophy of LES
• Increased incidence of esophageal cancer
• S/sx
– dysphagia (solid and liquid) -85-95%
– Regurgitation
– chest pain
– weight loss
– Difficulty belching
DISCUSSION
• PRIMARY achalasia (Idiopathic)
– Unknown cause of inflammatory neuronal
degeneration
• SECONDARY achalasia (pseudoachalasia)
– Recognized pathologic causes of esophageal
motility disorders
• Malignancy (especially gastric cancer) • Sarcoidosis
• Pseudo-obstruction
• MEN, Type 2B
• Neurofibromatosis
• Chagas’ disease • Eosinophilic gastroenteritis
• Juvenile Sjögren’s • Fabry’s disease
• Amyloidosis • Scleroderma
• Chronic idiopathic intestinal
DISCUSSION
De Leon, A. R., et. al., Association between idiopathic achalasia and IL23R gene. 31 MAR 2010
TREATMENT
• Medical management
• Mechanical dilation
• Chemical paralysis (Botulinum toxin)
• Surgical myotomy
TREATMENT
• Medical therapy
– Nitrates, calcium channel blockers (nifedipine)
• Cause smooth muscle relaxation but with limited
success
TREATMENT
• Pneumatic dilation of the LES
– Tears muscle fibers of LES, thus weakening it
• type and diameter of dilator,
• balloon inflation pressure and rate
• duration of inflation
• number of inflations per session
– Good short-term results
– Potential complications of esophageal
perforation (2-6%) and GERD
TREATMENT
• Botulinum toxin injection
– Inhibits release of excitatory acetylcholine from
nerve endings (thus causing lower LES pressures)
– Good short-term results, but long term efficacy
unknown
TREATMENT
• Surgical myotomy
– LES muscle fibers cut
– Laparoscopy becoming more popular
– Good relief of symptoms
– Superior method for achieving better long term
results
– Debate: fundoplication is necessary to prevent
longstanding GERD
PROGNOSIS
• prevalence of treated achalasia is
10.82/100,000
• stable incidence but a rising prevalence
• Survival of achalasia cases is significantly less
than age-matched healthy controls.
ETHICAL ISSUES
• DOUBLE EFFECTS
– An act is seen to have good and bad effects
– In order for the act to be permissible:
• Action must be good itself or at least morally indifferent
ETHICAL ISSUES
ETHICAL ISSUES
ETHICAL ISSUES
ETHICAL ISSUES
THANK YOU